Boston, MA, United States of America

Aaron K Remenschneider

This inventor holds 5 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Massachusetts Eye and Ear Infirmary, Harvard College. Active years: 2020-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Aaron K Remenschneider. Retrieved from https://idiyas.com/inventor/aaron-k-remenschneider

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 80.0

 

 

Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2020-2026

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Mind of Aaron K Remenschneider

Introduction: Aaron K Remenschneider is a distinguished inventor based in Boston, MA, known for his groundbreaking contributions to various fields.

Latest Patents: Aaron K Remenschneider holds several patents in the medical device industry, particularly in the development of innovative surgical tools and techniques.

Career Highlights: With a background in biomedical engineering, Aaron has successfully translated his expertise into practical solutions, earning recognition for his inventive spirit and problem-solving skills.

Collaborations: Throughout his career, Aaron has collaborated with leading researchers, healthcare professionals, and industry experts to bring his inventions to life and make a meaningful impact in the medical field.

Conclusion: Aaron K Remenschneider's passion for innovation and commitment to improving healthcare have solidified his reputation as a visionary inventor in Boston and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…